This article was written by Follow Terry Chrisomalis is a private investor in the Biotech sector with years of experience utilizing his Applied Science...
A company of Manulife Investment Management, John Hancock Investment Management serves investors through a unique multimanager approach, complementing our extensive in-house capabilities with an...
Introduction1 In the second quarter of 2023, the FPA U.S. Core Equity Fund’s (“Fund”) performance was 9.96% (10.31% before fees and expenses), which compares...
Business development companies have experienced phenomenal growth due to their floating-rate portfolios and growing demand for alternative financing. In particular, venture lending businesses such...